Recent Updates
Recently added Catalysts
PRGO Positive Sentiment Score: 75/100

Perrigo Announces Quarterly Dividend Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a...

Key Takeaway: Perrigo Company plc has announced the declaration of a quarterly dividend of $0.290 per share, which is payable to shareholders on September 16, 2025. Shareholders of record as of August 29, 2025, will receive this dividend. The company is recognized as a leader in the consumer self-care market, providing a range of health and wellness solutions, primarily in North America and Europe. Perrigo's business model supports a mix of private label offerings and well-known brands, ensuring accessibility to a variety of self-care products.

Market Sentiment Analysis

POSITIVE FACTORS

  • Perrigo declared a quarterly dividend of $0.290 per share.
  • The company has a strong history in providing self-care solutions.
  • Perrigo's business model supports both store brands and leading brands.

Full Press Release Details

DUBLIN , July 30, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO ), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0 .290 per share, payable on September 16, 2025 , to shareholders of record on August 29, 2025 .
Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe . As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.
Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill ® , Mederma ® , Compeed ® , EllaOne ® , and Jungle Formula ® .
For more information, visit www.perrigo.com .
Forward-Looking Statements
This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings , for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024 .
Perrigo Contact
Bradley Joseph , Vice President, Global Investor Relations & Corporate Communications, (269) 686-3373, E-mail: [email protected]
Nicholas Gallagher , Senior Manager, Global Investor Relations & Corporate Communications, (269) 686-3238, E-mail: [email protected]
SOURCE Perrigo Company plc

21 %

Frequently Asked Questions

What is Perrigo Company known for?

Perrigo Company is a leading provider of self-care products, offering health and wellness solutions.

When is Perrigo's next dividend payment?

Perrigo's next dividend of $0.290 per share will be paid on September 16, 2025.

How long has Perrigo been in business?

Perrigo has over a century of experience in the self-care market.

What type of products does Perrigo offer?

Perrigo offers over-the-counter self-care solutions available without a prescription.

Who to contact for Perrigo investor relations?

For investor relations, contact Bradley Joseph at (269) 686-3373.

Last updated: Jul 30, 2025